Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
We're researching and developing therapies for one of the largest genetic causes of autism and epilepsy - currently focused on loss of function SCN2A.
| $180.20% | |
| $30.03% | |
| $20.02% | |
| $0.760.01% | |
| $0.360.00% | |
| $0.200.00% | |
| $0.120.00% | |
| $0.090.00% | |
| $0.080.00% | |
| $0.080.00% | |
| $0.070.00% | |
| $0.060.00% |